Liquidia Technologies, Inc.
Clinical trials sponsored by Liquidia Technologies, Inc., explained in plain language.
-
New inhaled drug could help lung disease patients breathe easier and walk farther
Disease control Recruiting nowThis study tests an inhaled medicine called L606 for people with high blood pressure in the lungs due to lung disease. About 344 adults will be randomly assigned to receive L606 or a placebo. The main goal is to see if L606 helps them walk farther in six minutes and delays worsen…
Phase: PHASE3 • Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New inhaled powder for lung blood pressure condition tested in 80 patients
Disease control Recruiting nowThis study is testing the safety of an inhaled dry powder form of treprostinil (LIQ861) for people with pulmonary hypertension (high blood pressure in the lungs) due to lung disease. About 80 adults will take the drug using a special inhaler, and researchers will monitor for side…
Sponsor: Liquidia Technologies, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC